National Institutes of Health Director Francis Collins and FDA Commissioner Robert Califf got to joke around a little on stage at the Faster Cures Partnering for Cures meeting in New York Nov. 15. The exchanges were thoughtful and entertaining, but more than anything they served to underscore the uncertainty over the future direction of federal health policy after the surprise election of Donald Trump as president.
Califf appeared on a panel that Collins moderated about the challenges in pursing “big science” initiatives like the Precision Medicine initiative and the Cancer Moonshot. They engaged in a friendly...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?